Cargando…

Controversies in hormonal adjuvant therapy for premenopausal patients

Detalles Bibliográficos
Autor principal:	Howell, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284878/ http://dx.doi.org/10.1186/bcr2275

Ejemplares similares

Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Involuntary outpatient treatment: the data and controversy
por: Swartz, Marvin
Publicado: (2007)

The growing controversy about growth charts: WHO or regional?
por: Khadilkar, Vaman
Publicado: (2013)

Controversies of the assesment and management of polycystic ovary syndrome in adolescents
por: Peña, Alexia, et al.
Publicado: (2015)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Controversial Issue Session: Brace treatment in infantile scoliosis: benefits
por: Claude de Mauroy, Jean
Publicado: (2012)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Adjuvant therapy in colorectal cancer – studies of the FOGT group
por: Staib, Ludger, et al.
Publicado: (2010)

Controversies about the adjustment of gravitational valves in respect to a new device
por: Miethke, Christoph, et al.
Publicado: (2006)

Family-Based Treatment - the Victorian roll-out: strategies, controversies and outcomes
por: Pradel, Martin, et al.
Publicado: (2013)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Preoperative hormonal therapy: results and implications
por: Dowsett, M
Publicado: (2005)

Controversial Issue Session: Brace treatment in infantile scoliosis: brace treatment problems
por: Sánchez Pérez-Grueso, FJ
Publicado: (2012)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Monophosphoryl Lipid a as an adjuvant for immune therapy? A detailed in vitro comparison to LPS
por: Schülke, Stefan, et al.
Publicado: (2014)

Hormone replacement therapy, percent mammographic density and the sensitivity of mammography
por: Kavanagh, AM, et al.
Publicado: (2004)

How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013)

Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare
por: Müller, Volkmar, et al.
Publicado: (2023)

Menopause and hormone replacement therapy: effects on the immune system, arthritis and bone
por: Carlsten, H, et al.
Publicado: (2004)

Rationale for adjuvant measures in musculoskeletal diseases
por: Gast, Ulf
Publicado: (2013)

Radically resected node-negative squamous cell carcinoma of thoracic esophagus: recurrence pattern and indication for adjuvant therapy
por: Fang, W, et al.
Publicado: (2013)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Response to growth hormone therapy and gonadal pathology in 45,X/46,XY females
por: Titmuss, Angela, et al.
Publicado: (2015)

A giant intradiploic angiolipoma of the skull: controversies in diagnosis of skull bone lesions.Report of the second case reported in the literature and review of the literature
por: Ghassemi, Babak, et al.
Publicado: (2012)

Polymorphisms, endogenous hormone levels and familial breast cancer risk in premenopausal women
por: Walker, K, et al.
Publicado: (2010)

Luteinizing hormone-releasing hormone analogues--the rationale for adjuvant use in premenopausal women with early breast cancer.
por: Jonat, W.
Publicado: (1998)

Controversies in the Adjuvant Therapy of Endometrial Cancer
por: Hsiao, Sheng-Mou, et al.
Publicado: (2011)

Adjuvant chemotherapy for operable breast cancer: old vs new schema
por: Valagussa, P, et al.
Publicado: (2005)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Placental hormones and the control of fetal growth
por: Freemark, Michael
Publicado: (2015)

Effect of growth hormone on bone fragility in patients with Prader-Willi syndrome scoliosis
por: Nakamura, Yutaka, et al.
Publicado: (2015)

Hormones and radiation as risk factors for breast cancer
por: Beral, V
Publicado: (2006)

Hormonal interactions during mammary gland development
por: Vonderhaar, BK
Publicado: (2003)

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)

Growth regulation and steroid hormone resistance in breast cancer
por: Horwitz, KB
Publicado: (2000)

How safe is growth hormone treatment during childhood?
por: Cutfield, Wayne
Publicado: (2013)

Infiltration of dendritic cells and antigen uptake in the muscle after injection of HIV-1 Env gp120 in adjuvant
por: Liang, F, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_utq2nf5jjoac47hi91pina2j1j